What exactly do the advance purchase agreements between the European Union and the pharmaceutical industry on future Covid-19 vaccines contain? After gleaning information from the European Commission (see EUROPE B12554A4), MEPs were hoping to get more details from industry at a public hearing on Tuesday 22 September. But not surprisingly, it invoked the sacrosanct principle of business secrecy.
Refusal to publish agreements
As a reminder, the EU is negotiating with the pharmaceutical...